首页> 外文期刊>American Journal of Ophthalmology Case Reports >Use of laser iridoplasty in iris incarceration of a glaucoma drainage device
【24h】

Use of laser iridoplasty in iris incarceration of a glaucoma drainage device

机译:使用激光虹膜成形术在青光眼引流装置的虹膜陶瓷中

获取原文
获取外文期刊封面目录资料

摘要

PurposeTo describe the use of laser iridoplasty to release iris incarceration occluding a glaucoma drainage device.ObservationsA 46-year-old male with uncontrolled type 1 diabetes mellitus presented with neovascular glaucoma and subsequently had a glaucoma drainage device implanted for control of intraocular pressure. One month post-operatively, he presented with a significantly elevated intraocular pressure, thought to be due to poor drainage from iris incarceration in the device. He had recently developed a vitreous hemorrhage and hyphema, and he had florid neovascularization of the iris, thus raising concern that traditional neodymium:yttrium-aluminum-garnet (Nd:YAG) iridotomy would promote re-formation of the hyphema. Thus, a diode solid-state laser iridoplasty was performed around the site of incarceration, resulting in successful release of the iris from the device without hyphema formation.Conclusions and ImportanceGlaucoma drainage devices are effective tools to help control intraocular pressure. However, they risk post-operative complications, such as iris incarceration within the device, that prevents them from functioning properly. In such cases, Nd:YAG laser iridotomy is often used around the site of incarceration, thus releasing it from the device. In this case report, we describe how diode solid-state laser can be used to release the iris incarceration via iridoplasty. Such iridoplasty may result in a decreased likelihood of hyphema formation as compared to Nd:YAG iridotomy, so this provides a superior alternative in patients with a propensity for developing a hyphema, such as in patients with iris neovascularization.
机译:Purposeto描述了激光虹膜成形术以释放虹膜射出的虹膜排放装置,遮挡了青光眼引流装置。食物46岁男性,其中包含新生血管型青光眼的不受控制的1型糖尿病,随后植入青光眼引流装置,用于控制眼压的控制。手术后一个月,他呈现出明显升高的眼压压力,认为是由于装置中虹膜释放的差。他最近开发了一种玻璃体出血和QUPHEMA,他曾冒着虹膜的虹膜,从而提高了传统的钕:钇 - 铝 - 石榴石(ND:YAG)虹膜术将促进Quphema的重新形成。因此,围绕着定位的二极管固态激光铱成形术,导致从没有蛋白形成的器件中成功释放虹膜。结论和重要性引导装置是有效的工具,以帮助控制眼内压力。但是,它们风险术后并发症,例如设备内的虹膜监控,这可以防止它们正常运行。在这种情况下,Nd:YAG激光虹膜透明度通常在陶瓷部位周围使用,从而从装置释放它。在本例报告中,我们描述了二极管固态激光如何通过虹膜成形术释放虹膜释放。与ND:YAG虹膜膜相比,这种虹膜成形术可能导致猝灭形成的可能性降低,因此这为患者提供了一种用于开发Quphema的倾向的患者提供了优异的替代方案,例如虹膜新生血管患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号